Scheduled maintenance until 6:00 AM EST.
Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
ID: 345099Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $325K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Dec 23, 2022 12:00 AM
  4. 4
    Due Nov 18, 2024 12:00 AM
Description

The National Institutes of Health is offering a grant opportunity titled "Pilot Studies for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)". This grant aims to support research projects that collect pilot data to test pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline, Alzheimer's disease (AD), and Alzheimer's disease-related dementias (ADRD). The funding opportunity seeks to stimulate studies that enhance trial design and methods. The grant does not require cost sharing or matching. The maximum award ceiling is $325,000. The eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The closing date for applications is November 18, 2024. For more information and to apply, visit the following link: Pilot Studies for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline Grant. For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
Files
Title
Posted
4/20/2024
Similar Opportunities
Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)". This grant aims to support the development and implementation of clinical trials for pharmacological and non-pharmacological interventions to prevent and treat the cognitive, behavioral, and neuropsychiatric changes associated with age-related cognitive decline, Alzheimer's disease (AD), and Alzheimer's disease-related dementias (ADRD). The grant also aims to stimulate studies that enhance trial design and methods. The funding instrument for this opportunity is a grant, and there is no cost sharing or matching requirement. The category of funding activity is health, and the opportunity falls under the discretionary category. The CFDA number associated with this grant is 93.866. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the federal government, faith-based or community-based organizations, Hispanic-serving institutions, historically Black colleges and universities (HBCUs), Indian/Native American tribal governments, non-domestic entities (foreign organizations), regional organizations, tribally controlled colleges and universities (TCCUs), and U.S. territories or possessions. The closing date for applications is October 17, 2024, and the archive date is November 22, 2024. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-011.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-011.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Early and Late Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)". This grant aims to support the development and implementation of clinical trials for cognitive and neuropsychiatric changes associated with age-related cognitive decline, Alzheimer's disease (AD), and Alzheimer's disease-related dementias (ADRD). The trials will cover the entire spectrum of the disease, from pre-symptomatic to more severe stages. The funding will be used to explore both pharmacological and non-pharmacological interventions. The NIH is particularly interested in proposals that enhance trial design and methods. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for applications is January 7, 2025. For more information and to apply, visit the NIH grants website at [http://grants.nih.gov/grants/guide/pa-files/PAR-23-081.html](http://grants.nih.gov/grants/guide/pa-files/PAR-23-081.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant for research on current topics in Alzheimer's Disease and its related dementias. This grant opportunity aims to support research projects that focus on understanding and addressing the challenges associated with Alzheimer's Disease and related dementias. The funding instrument for this opportunity is a grant, and there is no cost sharing or matching requirement. The category of funding activity is Health. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities, Regional Organizations, Tribally Controlled Colleges and Universities, and U.S. Territories or Possessions. The closing date for applications is November 12, 2024. For more information and to apply, please visit the following website: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-093.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-093.html).
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant for research on current topics in Alzheimer's Disease and its related dementias. This grant aims to support the development of new tests, animal models, techniques, and more to advance research in this field. The funding opportunity is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The grant does not require cost sharing or matching. The maximum award ceiling is $275,000. The deadline for applications is November 12, 2024. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-094.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-094.html).
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)". This grant is in the category of Health and falls under the funding instrument type of Grant. Small businesses are eligible to apply for this grant. The aim of this funding opportunity is to support research that may lead to the development of innovative products and/or services with the potential to advance progress in preventing and treating Alzheimer's disease (AD) and AD-related dementias (ADRD) and/or caring for and treating patients living with AD/ADRD. The grant does not require cost sharing or matching. The maximum award ceiling for this grant is $1,838,436. The closing date for applications is September 5, 2025. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAS-22-197.html](http://grants.nih.gov/grants/guide/pa-files/PAS-22-197.html). For any inquiries, please contact NIH OER Webmaster at OERWebmaster03@od.nih.gov.